Novonesis (novozymes) BNVZMF
13F holders, Q1 2024 (March 31)1holders
$58.66avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Novonesis (novozymes) B (NVZMF) in their 13F filings. The largest holder was Boston Common Asset Management, LLC ($2.5M).
- Company
- Novonesis (novozymes) B
- Filed as
- NOVOZYMES A/S (Q1 2024)
- CUSIP
- K7317J133
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $3.2M |
Ownership 1 holders
| Boston Common Asset Management, LLC | 0.06% | Reduce -20.9% | 42,415 | $2.5M |
"% of holder's portfolio" is NVZMF's weight in each manager's 13F, not the share of Novonesis (novozymes) B the manager owns.